[ovid] Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin-Naive Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes |
发布
回复
积分
10
10
Insights into the pathogenic role of neutrophils in systemic lupus erythematosus
10
Glaucoma tube shunts: 2026 Update
30
Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin-Naive Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes
10
Navigating the New Landscape: A Clinical Commentary on the 2026 AUA Guideline on Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
20
Early Cholecystectomy Safely Decreases Hospital Stay in Patients With Mild Gallstone Pancreatitis
